129 related articles for article (PubMed ID: 9751363)
41. Disease progression and survival in patients with prostate carcinoma and positive lymph nodes after radical retropubic prostatectomy.
Kroepfl D; Loewen H; Roggenbuck U; Musch M; Klevecka V
BJU Int; 2006 May; 97(5):985-91. PubMed ID: 16643480
[TBL] [Abstract][Full Text] [Related]
42. Long-term oncologic results of salvage radical prostatectomy for locally recurrent prostate cancer after radiotherapy.
Bianco FJ; Scardino PT; Stephenson AJ; Diblasio CJ; Fearn PA; Eastham JA
Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):448-53. PubMed ID: 15890586
[TBL] [Abstract][Full Text] [Related]
43. Impact of obesity on the utility of preoperative prostate-specific antigen velocity to predict for relapse after prostatectomy: a report from the SEARCH database.
King CR; Freedland SJ; Terris MK; Kane CJ; Amling CL; Aronson WJ; Presti JC
Urology; 2007 May; 69(5):921-6. PubMed ID: 17482935
[TBL] [Abstract][Full Text] [Related]
44. Changing nature of high risk patients undergoing radical prostatectomy.
Kane CJ; Presti JC; Amling CL; Aronson WJ; Terris MK; Freedland SJ;
J Urol; 2007 Jan; 177(1):113-7. PubMed ID: 17162017
[TBL] [Abstract][Full Text] [Related]
45. Long-term survival probability in men with clinically localized prostate cancer treated either conservatively or with definitive treatment (radiotherapy or radical prostatectomy).
Tewari A; Raman JD; Chang P; Rao S; Divine G; Menon M
Urology; 2006 Dec; 68(6):1268-74. PubMed ID: 17169648
[TBL] [Abstract][Full Text] [Related]
46. Update on Memorial Sloan-Kettering Cancer Center studies of neoadjuvant hormonal therapy for prostate cancer.
Fair WR; Betancourt JE
Mol Urol; 2000; 4(3):241-8;discussion 249-50. PubMed ID: 11062380
[TBL] [Abstract][Full Text] [Related]
47. Improved biochemical relapse-free survival with increased external radiation doses in patients with localized prostate cancer: the combined experience of nine institutions in patients treated in 1994 and 1995.
Kupelian P; Kuban D; Thames H; Levy L; Horwitz E; Martinez A; Michalski J; Pisansky T; Sandler H; Shipley W; Zelefsky M; Zietman A
Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):415-9. PubMed ID: 15667961
[TBL] [Abstract][Full Text] [Related]
48. Predictors of prostate cancer-specific mortality after radical prostatectomy or radiation therapy.
Zhou P; Chen MH; McLeod D; Carroll PR; Moul JW; D'Amico AV
J Clin Oncol; 2005 Oct; 23(28):6992-8. PubMed ID: 16192586
[TBL] [Abstract][Full Text] [Related]
49. Deoxyribonucleic acid ploidy and serum prostate specific antigen predict outcome following salvage prostatectomy for radiation refractory prostate cancer.
Amling CL; Lerner SE; Martin SK; Slezak JM; Blute ML; Zincke H
J Urol; 1999 Mar; 161(3):857-62; discussion 862-3. PubMed ID: 10022701
[TBL] [Abstract][Full Text] [Related]
50. Results of three dimensional conformal radiotherapy and hormonal therapy for local recurrence after radical prostatectomy.
Schwarz R; Krüll A; Tribius S; Alberti W
Strahlenther Onkol; 2005 Jul; 181(7):442-7. PubMed ID: 15995837
[TBL] [Abstract][Full Text] [Related]
51. Impact of obesity on prostate cancer recurrence after radical prostatectomy: data from CaPSURE.
Bassett WW; Cooperberg MR; Sadetsky N; Silva S; DuChane J; Pasta DJ; Chan JM; Anast JW; Carroll PR; Kane CJ
Urology; 2005 Nov; 66(5):1060-5. PubMed ID: 16286124
[TBL] [Abstract][Full Text] [Related]
52. Results of hospital cancer registry surveys by the American College of Surgeons: outcomes of prostate cancer treatment by radical prostatectomy.
Mettlin CJ; Murphy GP; Sylvester J; McKee RF; Morrow M; Winchester DP
Cancer; 1997 Nov; 80(9):1875-81. PubMed ID: 9351563
[TBL] [Abstract][Full Text] [Related]
53. Focal cryotherapy for localized prostate cancer: a report from the national Cryo On-Line Database (COLD) Registry.
Ward JF; Jones JS
BJU Int; 2012 Jun; 109(11):1648-54. PubMed ID: 22035200
[TBL] [Abstract][Full Text] [Related]
54. Prostate cancer treatment in Europe at the end of 1990s.
Gatta G; Zigon G; Buemi A; Coebergh JW; Colonna M; Contiero P; Denis L; Grosclaude P; Guizard AV; Sanchez-Perez MJ; Plesko I; Ondrusova M; Rachtan J; Valdagni R; Velten M; Vercelli M; Berrino F
Acta Oncol; 2009; 48(6):867-73. PubMed ID: 19235570
[TBL] [Abstract][Full Text] [Related]
55. [Changes in immunoparameters following cryosurgery in prostate cancer].
Fukagai T; Tazawa K; Higaki Y; Imamura K
Hinyokika Kiyo; 1990 Mar; 36(3):307-17. PubMed ID: 2353604
[TBL] [Abstract][Full Text] [Related]
56. Acute renal failure with thrombocytopenia after cryosurgery of the prostate.
Kohn IJ; Heifets M; Fisher S; Seidmon EJ
Tech Urol; 1996; 2(4):230-3. PubMed ID: 9085545
[TBL] [Abstract][Full Text] [Related]
57. [Survival of patients with cancer of the prostate].
Denis R
J Urol Nephrol (Paris); 1972; 78(7):641-7. PubMed ID: 4653665
[No Abstract] [Full Text] [Related]
58. Humoral immunity following double freezing of the prostate of patients with prostatic cancer.
Ueda K; Ohtaguro K; Washida H; Jinno H; Fushimi N; Masegi T
Prog Clin Biol Res; 1982; 107():815-26. PubMed ID: 7167530
[TBL] [Abstract][Full Text] [Related]
59. [Cryotherapy in 141 cases of carcinoma of the prostate reviewed after 5 years (author's transl)].
Sesia G; De Luca G; Chiaudano C; Cauda F
J Urol (Paris); 1982; 88(3):155-8. PubMed ID: 7097031
[TBL] [Abstract][Full Text] [Related]
60. Precipitating antibody in the sera of patients treated cryosurgically for carcinoma of the prostate.
Ablin RJ; Pfeiffer L; Gonder MJ; Soanes WA
Exp Med Surg; 1969; 27(4):406-10. PubMed ID: 4193317
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
